메뉴 건너뛰기




Volumn 17, Issue 10, 2002, Pages 1825-1828

Active immunization against hepatitis A in dialysis patients

Author keywords

Dialysis patients; Feasibility; Hepatitis A; Immunization; Immunogenecity; Reactogenicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; ASPARTATE AMINOTRANSFERASE; ERYTHROPOIETIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; INACTIVATED VIRUS VACCINE; LACTATE DEHYDROGENASE; LIVER ENZYME;

EID: 0036798105     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.10.1825     Document Type: Article
Times cited : (18)

References (23)
  • 1
    • 0001822571 scopus 로고
    • Global impact of hepatitis A virus infection: Changing patterns
    • Hollinger FB, Lemon SM, Margolis HS, eds. Baltimore, Williams and Wilkins
    • Hadler SC. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral Hepatitis and Liver Disease. Baltimore, Williams and Wilkins, 1991; 14-20
    • (1991) Viral Hepatitis and Liver Disease , pp. 14-20
    • Hadler, S.C.1
  • 2
    • 0026472631 scopus 로고
    • Epidemiological patterns of hepatitis A in different parts of the world
    • Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992; 10: S56-S62
    • (1992) Vaccine , vol.10
    • Gust, I.D.1
  • 3
    • 0026483854 scopus 로고
    • Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: Rationale and summary of findings
    • Andre F, D'Hondt E, Delem A, Safary A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine 1992; 10: S160-S168
    • (1992) Vaccine , vol.10
    • Andre, F.1    D'Hondt, E.2    Delem, A.3    Safary, A.4
  • 4
    • 0026556244 scopus 로고
    • Clinical trial with inactivated hepatitis vaccine and recommendations for its use
    • Tilzey AJ, Palmer SJ, Barrow S et al. Clinical trial with inactivated hepatitis vaccine and recommendations for its use. Br Med J 1992; 304: 1272-1276
    • (1992) Br. Med. J , vol.304 , pp. 1272-1276
    • Tilzey, A.J.1    Palmer, S.J.2    Barrow, S.3
  • 5
    • 0027325769 scopus 로고
    • Active immunization against hepatitis A. Comparison of various immunization schedules
    • Muller R, Bock HL, Clemens R, Jilg W. Active immunization against hepatitis A. Comparison of various immunization schedules. Dtsch Med Wochenschr 1993; 118: 1101-1104
    • (1993) Dtsch. Med. Wochenschr , vol.118 , pp. 1101-1104
    • Muller, R.1    Bock, H.L.2    Clemens, R.3    Jilg, W.4
  • 6
    • 0026643021 scopus 로고
    • A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
    • Werzberger A, Mensch B, Kuter B et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327: 453-457
    • (1992) N. Engl. J. Med , vol.327 , pp. 453-457
    • Werzberger, A.1    Mensch, B.2    Kuter, B.3
  • 7
    • 0028556678 scopus 로고
    • Single dose inactivate hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity
    • Van Damme P, Mathei C, Thoelen S et al. Single dose inactivate hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. J Med Virol 1994; 44: 435-441
    • (1994) J. Med. Virol , vol.44 , pp. 435-441
    • Van Damme, P.1    Mathei, C.2    Thoelen, S.3
  • 8
    • 0031021442 scopus 로고    scopus 로고
    • Vaccines to prevent viral hepatitis
    • Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997; 336: 196-204
    • (1997) N. Engl. J. Med , vol.336 , pp. 196-204
    • Lemon, S.M.1    Thomas, D.L.2
  • 9
    • 0028300243 scopus 로고
    • Immune response after hepatitis A vaccination in hemodialysis patients: Comparison with hepatitis B vaccination
    • Kuramoto I, Fujiyama S, Matsushita K, Sato T. Immune response after hepatitis A vaccination in hemodialysis patients: Comparison with hepatitis B vaccination. J Gastroenterol Hepatol 1994; 9: 228-231
    • (1994) J. Gastroenterol. Hepatol , vol.9 , pp. 228-231
    • Kuramoto, I.1    Fujiyama, S.2    Matsushita, K.3    Sato, T.4
  • 10
    • 0035957964 scopus 로고    scopus 로고
    • Recommendations for preventing transmission of infections among chronic hemodialysis patients
    • Centers for Disease Control and Prevention (CDC) 27 April RR-5
    • Centers for Disease Control and Prevention (CDC) Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR, 27 April 2001 50 RR-5
    • (2001) MMWR , vol.50
  • 11
    • 0032801079 scopus 로고    scopus 로고
    • Vaccination against hepatitis A and B in chronic liver disease
    • Keeffe EB. Vaccination against hepatitis A and B in chronic liver disease. Viral Hepatitis Rev 1999; 5: 77-88
    • (1999) Viral Hepatitis Rev , vol.5 , pp. 77-88
    • Keeffe, E.B.1
  • 13
    • 0029761219 scopus 로고    scopus 로고
    • Inactivated hepatitis A vaccine (HM175 strain): A preliminary review of its immunogenicity, protective potential and tolerability in at-risk patients
    • Wagstaff AJ, Plosker GL, Balfour J. Inactivated hepatitis A vaccine (HM175 strain): a preliminary review of its immunogenicity, protective potential and tolerability in at-risk patients. Clin Immunother 1996; 6: 68-88
    • (1996) Clin. Immunother , vol.6 , pp. 68-88
    • Wagstaff, A.J.1    Plosker, G.L.2    Balfour, J.3
  • 14
    • 0031811589 scopus 로고    scopus 로고
    • Two-year review of hepatitis A vaccine safety: Data from the vaccine adverse event reporting system (VAERS)
    • Niu MT, Salive M, Krueger N, Ellenberg SS. Two-year review of hepatitis A vaccine safety: data from the vaccine adverse event reporting system (VAERS). Clin Infect Dis 1998; 26: 1475-1476
    • (1998) Clin. Infect Dis , vol.26 , pp. 1475-1476
    • Niu, M.T.1    Salive, M.2    Krueger, N.3    Ellenberg, S.S.4
  • 15
    • 0029901455 scopus 로고    scopus 로고
    • Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other travellers vaccines with the immune response
    • Bienzle U, Bock HL, Kruppenbacher JP et al. Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other travellers vaccines with the immune response. Vaccine 1996; 14: 501-505
    • (1996) Vaccine , vol.14 , pp. 501-505
    • Bienzle, U.1    Bock, H.L.2    Kruppenbacher, J.P.3
  • 16
    • 0032966129 scopus 로고    scopus 로고
    • Protective effect of hepatitis B vaccine in chronic hemodialysis patients
    • Miller E, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 1999; 33: 356-360
    • (1999) Am. J. Kidney Dis , vol.33 , pp. 356-360
    • Miller, E.1    Alter, M.J.2    Tokars, J.I.3
  • 18
    • 0033765040 scopus 로고    scopus 로고
    • A randmomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients
    • Charest AF, McDougall J, Goldstein MB. A randmomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 2000; 36: 976-982
    • (2000) Am. J. Kidney Dis , vol.36 , pp. 976-982
    • Charest, A.F.1    McDougall, J.2    Goldstein, M.B.3
  • 19
    • 0021204123 scopus 로고
    • Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy
    • Stevens CE, Alter HJ, Taylor PE et al. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 1984; 311: 496-501
    • (1984) N. Engl. J. Med , vol.311 , pp. 496-501
    • Stevens, C.E.1    Alter, H.J.2    Taylor, P.E.3
  • 20
    • 0029836718 scopus 로고    scopus 로고
    • A study to assess the immunogenicity, reactogenicity and safety of hepatitis A vaccine administered subcutaneously to patients with congenital coagulation disorders
    • Zuckerman JN, Moore S, Smith J et al. A study to assess the immunogenicity, reactogenicity and safety of hepatitis A vaccine administered subcutaneously to patients with congenital coagulation disorders. Haemophilia 1996; 2: 235-239
    • (1996) Haemophilia , vol.2 , pp. 235-239
    • Zuckerman, J.N.1    Moore, S.2    Smith, J.3
  • 21
    • 0034106762 scopus 로고    scopus 로고
    • Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia
    • Ragni MV, Lusher JM, Koerper MA, Manco-Johnson M, Krause DS. Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia. Haemophilia 2000; 6: 98-103
    • (2000) Haemophilia , vol.6 , pp. 98-103
    • Ragni, M.V.1    Lusher, J.M.2    Koerper, M.A.3    Manco-Johnson, M.4    Krause, D.S.5
  • 22
    • 0031915859 scopus 로고    scopus 로고
    • Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
    • Keeffe EB, Iwarson S, McMahon BJ et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998; 27: 881-886
    • (1998) Hepatology , vol.27 , pp. 881-886
    • Keeffe, E.B.1    Iwarson, S.2    McMahon, B.J.3
  • 23
    • 0032712249 scopus 로고    scopus 로고
    • Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recients
    • Stark K, Günther M, Neuhaus R et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant reci ents. J Infect Dis 1999; 180: 2014-2017
    • (1999) J. Infect Dis , vol.180 , pp. 2014-2017
    • Stark, K.1    Günther, M.2    Neuhaus, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.